LEXX (Lexaria Bioscience Corp. Common Stock) Stock Analysis - Analyst Ratings

Lexaria Bioscience Corp. Common Stock (LEXX) is a publicly traded Healthcare sector company. As of May 19, 2026, LEXX trades at $0.57 with a market cap of $14.68M and a P/E ratio of 0.00. LEXX moved -0.07% today. Year to date, LEXX is -14.36%; over the trailing twelve months it is -44.54%. Its 52-week range spans $0.46 to $3.39. Rallies surfaces LEXX's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.

What do analysts rate LEXX?

The average price target is $0.00.

LEXX Key Metrics

Key financial metrics for LEXX
MetricValue
Price$0.57
Market Cap$14.68M
P/E Ratio0.00
EPS$0.00
Dividend Yield0.00%
52-Week High$3.39
52-Week Low$0.46
Volume38.08K
Avg Volume0
Revenue (TTM)$705.92K
Net Income$-11.91M
Gross Margin99.61%

LEXX Analyst Consensus

LEXX analyst coverage data. Average price target: $0.00.

Latest LEXX News

Recent LEXX Insider Trades

  • BUNKA CHRISTOPHER bought 11.90K (~$10.87K) on Jul 30, 2025.
  • BUNKA CHRISTOPHER bought 15.60K (~$14.38K) on Jul 29, 2025.
  • McKechnie William Edward bought 5.00K (~$4.53K) on Jul 29, 2025.

Common questions about LEXX

What do analysts rate LEXX?
The average price target is $0.00.
Does Rallies show LEXX price targets?
Yes. Rallies tracks LEXX analyst ratings, consensus rating, average price target, upgrades, downgrades, analyst firms, and recent price target changes when available.
Is LEXX research on Rallies investment advice?
No. Rallies provides research, data, and educational context for LEXX. It does not provide personalized investment advice.
LEXX

LEXX